The Enterprise Value as of December 2025 (TTM) for RBC Bioscience Corporation (6848.TWO) is 619.67M

According to RBC Bioscience Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 619.67M. This represents a change of 2.88% compared to the average of 602.34M of the last 4 quarters.

RBC Bioscience Corporation (6848.TWO) Historical Enterprise Value (quarterly & annually)

How has 6848.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of RBC Bioscience Corporation over the last ten years is 576.91M. The current 619.67M Enterprise Value has changed 10.64% with respect to the historical average. Over the past ten years (40 quarters), 6848.TWO's Enterprise Value was at its highest in in the December 2021 quarter at 825.60M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

RBC Bioscience Corporation (6848.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RBC Bioscience Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RBC Bioscience Corporation (6848.TWO) Average Enterprise Value

How has 6848.TWO Enterprise Value performed in the past?

The current Enterprise Value of RBC Bioscience Corporation (6848.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

RBC Bioscience Corporation (6848.TWO) Enterprise Value vs. Peers

How is 6848.TWO’s Enterprise Value compared to its peers?

RBC Bioscience Corporation’s Enterprise Value is greater than Feng Chi Biotech Corp. (276.92M), greater than Visgeneer Inc. (334.94M), greater than iXensor Co., Ltd. (273.39M), greater than UniPharma Co., Ltd. (394.47M), less than DuoGenic StemCells corporation (680.91M), greater than EPS Bio Technology Corp. (387.95M), less than Taiwan Advanced Nanotech Inc. (634.94M), less than BioLASCO Taiwan Co., Ltd. (811.96M), greater than TaiwanJ Pharmaceuticals Co., Ltd. (610.53M), greater than Vectorite Biomedical Inc. (599.37M),

Build a custom stock screener for RBC Bioscience Corporation (6848.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RBC Bioscience Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RBC Bioscience Corporation (6848.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RBC Bioscience Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.